Dr. Andrew Norden
Chief Medical Officer
Dr. Norden is a neuro-oncologist and physician executive who joined Cota in 2017 as Chief Medical Officer.
Prior to joining Cota, Dr. Norden served as Deputy Chief Health Officer and lead physician for oncology and genomics at IBM Watson Health. Previously he worked at Dana-Farber Cancer Institute in Boston in several capacities, including Associate Chief Medical Officer and Medical Director of Satellites and Network Affiliates. Dr. Norden served as physician leader for the Dana-Farber community network for more than 5 years.
A talented physician and board-certified neurologist and neuro-oncologist, Dr. Norden cares for patients with brain tumors and neurological complications of cancer. He has also developed many clinical trials for patients with glioma, meningioma, and seizures in brain tumor patients. He is the author of more than 65 peer-reviewed papers primarily involving therapy for high-grade gliomas and meningioma. He is an active member of the American Society of Clinical Oncology, the Society for Neuro-Oncology, and the American Academy of Neurology, and he is an Associate Editor of JCO-Clinical Cancer Informatics.
Dr. Norden attended medical school at Yale School of Medicine before moving to Boston for residency training at Massachusetts General and Brigham and Women’s Hospitals. After serving as Chief Resident, he completed a neuro-oncology fellowship at Dana-Farber. Dr. Norden also earned an MPH degree from Harvard School of Public Health and an MBA from University of Massachusetts, Amherst. His received his undergraduate degree in neuroscience from Brown University.
Dr. Norden lives outside Boston with his wife and three young sons. In his free time, he enjoys snow-skiing, running, and watching his sons play sports.